HOWL
Werewolf Therapeutics, Inc.
+0.05 (+5.53%)0.97USD262K成交股數47.1M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-30下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.2M | 8.2M | 11.6M | 13.1M | 13.1M | 15.7M | 12.5M | 15.3M | 12.9M | 10.8M | 9.6M | 11.7M |
| 銷售管理費用 | 7.7M | 5.1M | 4.1M | 4.4M | 4.9M | 4.6M | 4.6M | 4.8M | 5.0M | 4.3M | 4.6M | 5.0M |
| 營業利益 | 7.2M-140% | −13.3M-35% | −15.7M-8% | −17.5M-7% | −18.0M+5% | −20.3M+120% | −17.1M+182% | −19.0M+55% | −17.2M | −9.3M | −6.1M | −12.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | 3.7M-120% | −13.5M-34% | −16.4M-2% | −18.0M+4% | −18.1M+12% | −20.4M+146% | −16.7M+227% | −17.2M+44% | −16.2M | −8.3M | −5.1M | −12.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | 0.08-120% | -0.28-35% | -0.36-5% | -0.40-7% | -0.40+3% | -0.43+87% | -0.38+171% | -0.43+26% | -0.39 | -0.23 | -0.14 | -0.34 |
| 稀釋股數 | 48.6M | 49.4M | 45.8M | 45.0M | 44.8M | 43.9M | 43.7M | 44.0M | 41.6M | 35.7M | 35.6M | 34.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 22.0M | 46.5M | 65.7M | 77.6M | 92.0M | 111M | 123M | 135M | 139M | 130M | 137M | 148M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 24.2M | 58.0M | 79.6M | 92.6M | 107M | 127M | 140M | 154M | 178M | 176M | 185M | 195M |
| 有息負債 | – | 32.1M | 32.1M | 32.1M | 32.1M | 32.1M | 32.1M | 32.1M | 40.0M | – | – | – |
| 總負債 | 7.9M | 45.8M | 50.0M | 51.1M | 49.9M | 53.5M | 50.7M | 49.7M | 60.0M | 63.9M | 66.6M | 74.0M |
| 股東權益 | 16.3M | 12.2M | 29.6M | 41.5M | 57.3M | 73.4M | 89.4M | 104M | 118M | 112M | 119M | 121M |
| 負債比 | 32.6% | 79.0% | 62.8% | 55.2% | 46.6% | 42.2% | 36.2% | 32.3% | 33.8% | 36.3% | 36.0% | 37.9% |
| 淨現金(現金 − 有息負債) | – | 14.4M | 33.6M | 45.5M | 60.0M | 78.9M | 90.7M | 103M | 99.2M | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −10.6M | – | – | −18.9M+24% | – | – | – | −15.3M | – | – | −9.9M |
| 資本支出 | – | – | – | – | 0 | – | – | – | 111K | – | – | 168K |
| 自由現金流 | – | – | – | – | −18.9M+23% | – | – | – | −15.4M | – | – | −10.1M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −60.8M | –% | -1.33 | −60.3M |
| FY2024 | – | – | −70.5M | –% | -1.63 | −56.4M |
| FY2023 | – | – | −37.4M | –% | -1.05 | −33.4M |
| FY2022 | – | – | −53.8M | –% | -1.86 | −44.2M |
| FY2021 | – | – | −50.0M | –% | -10.94 | −43.4M |
| FY2020 | – | – | −15.0M | –% | -28.08 | −19.2M |